Redhill Biopharma
RDHL
18 hedge funds and large institutions have $21.2M invested in Redhill Biopharma in 2015 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 3 closing their positions.
200% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 3
50% more funds holding
Funds holding: 12 → 18 (+6)
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
3% more capital invested
Capital invested by funds: $20.6M → $21.2M (+$637K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FAM
Fred Alger Management
New York
|
+$556K |
| 2 |
BHB
Bank Hapoalim BM
Tel Aviv,
Israel
|
+$476K |
| 3 |
Renaissance Technologies
New York
|
+$429K |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$333K |
| 5 |
LWM
Lyons Wealth Management
Winter Park,
Florida
|
+$191K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
-$1.92M |
| 2 |
BC
Broadfin Capital
New York
|
-$1.59M |
| 3 |
SM
Sabby Management
Miami Beach,
Florida
|
-$1.57M |
| 4 |
Goldman Sachs
New York
|
-$422K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$38K |
RDHL Hedge Fund Activity: Q2 2015 in Review
18 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in Redhill Biopharma (RDHL) for Q2 2015, worth a combined $21.2M — up 3.1% from $20.6M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new RDHL positions and 3 closed out — a net gain of 6 holders — while 3 added to existing stakes and 2 trimmed.
The largest buyer was Fred Alger Management, opening a new position worth an estimated $556K. The largest seller was OrbiMed, cutting an estimated $1.92M.
- 18 institutional investors held Redhill Biopharma (RDHL) as of Q2 2015, up from 12 in Q1 2015.
- Funds reported $21.2M of Redhill Biopharma stock for Q2 2015, up 3.1% quarter-over-quarter.
- 9 funds opened new Redhill Biopharma positions in Q2 2015 and 3 closed out, a net change of +6 holders.
- The largest Redhill Biopharma buyer in Q2 2015 was Fred Alger Management, an estimated $556K added.
- The largest Redhill Biopharma seller in Q2 2015 was OrbiMed, an estimated $1.92M sold.
Based on aggregated 13F filings for Q2 2015.